← Back
$RYTM All transactions

RHYTHM PHARMACEUTICALS, INC.

▼ SELL 10b5-1 Plan

$ Value

$439K

Shares

6,745

Price

$65

Filed

May 1

Insider

Name

Mazabraud Yann

Title

EVP, Head of International

CIK

0001774702

Roles

Officer

Transaction Details

Transaction Date

2025-04-29

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

37,655

Footnotes

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024. | The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $65.00 to $65.22 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Filing Info

Accession No.

0001104659-25-043555

Form Type

4

Issuer CIK

0001649904

Mazabraud Yann's History

Date Ticker Type Value
2026-04-01 RYTM M
2026-04-01 RYTM M $0
2026-04-01 RYTM M $0
2026-02-01 RYTM M
2026-02-01 RYTM M $0
2025-04-29 RYTM $439K

Other Insiders at RYTM (90d)

Insider Bought Sold Last
German Christopher Paul
Corporate Controller & CAO
2026-02-01
Popovits Kimberly J 2026-04-01
Meeker David P
President and CEO
2026-02-01
Smith Hunter C
Chief Financial Officer
$703K 2026-02-05
Mazabraud Yann
EVP, Head of International
2026-04-01
Lee Jennifer Kayden
EVP, Head of North America
2026-02-01
Cramer Pamela J.
Chief Human Resources Officer
2026-02-01
Shulman Joseph
Chief Technical Officer
2026-02-01
Garfield Alastair
Chief Scientific Officer
2026-02-01